Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:AstraZeneca
|
| gptkbp:acquisitionYear |
2013
|
| gptkbp:focusesOn |
inhaled combination therapies for respiratory diseases
|
| gptkbp:foundedIn |
2006
|
| gptkbp:founder |
Perry Nisen
Stephen K. Doberstein |
| gptkbp:headquartersLocation |
gptkb:Redwood_City,_California,_United_States
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:notableProduct |
PT003 (LAMA/LABA combination for COPD)
|
| gptkbp:bfsParent |
gptkb:AstraZeneca_plc
|
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
Pearl Therapeutics (2013)
|